Market Cap 1.35B
Revenue (ttm) 0.00
Net Income (ttm) -227.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.24
Volume 1,136,749
Avg Vol 1,050,604
Day's Range N/A - N/A
Shares Out 71.73M
Stochastic %K 43%
Beta 1.01
Analysts Strong Sell
Price Target $29.46

Company Profile

MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerla...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 415108022
Address:
Dorfstrasse 29, Zug, Switzerland
thezat
thezat May. 13 at 8:37 PM
$MLTX another day closer to a pop or a drop!
1 · Reply
Creisi
Creisi May. 13 at 8:23 PM
$MLTX Preplanned share sale adopted under Rule 10b-5 of the SEC Rules back in 2025... details are disclosed on the filing. This makes this transaction meaningless in terms of how insiders view the company's future. This is actually the last few shares from the 10b-5 TRADING PLAN, which saw the April disposition under the same preplanned dispositions. See attached:
2 · Reply
AXMO
AXMO May. 13 at 8:17 PM
$MLTX https://ir.moonlaketx.com/sec-filings/sec-filing/4/0001213900-26-055799
1 · Reply
Cardwizard
Cardwizard May. 13 at 8:10 PM
$MLTX oh boy up 19 pennies we’re breaking all kind of records now ,, oh well I guess Green is Green, but I could’ve made more today in my fucking savings account at my local bank. 🏦
0 · Reply
insomniaot7
insomniaot7 May. 13 at 8:04 PM
$MLTX congrats on the green day! Didn't even have to fly to China LOL
0 · Reply
TradesTyrone
TradesTyrone May. 13 at 7:45 PM
$MLTX wen 60
0 · Reply
kuwoson
kuwoson May. 13 at 7:25 PM
$MLTX At what point will there be new buyout offers (assuming big pharma is seriously considering one)? I'm not familiar with the mechanisms for acquisitions in the pharmaceutical industry, but isn't there a risk for potential buyers that an acquisition will become increasingly expensive?
1 · Reply
Rockybhai7239
Rockybhai7239 May. 13 at 7:25 PM
$MLTX how can you miss blackrock 1M shares 256% increase
0 · Reply
EZ_Money11
EZ_Money11 May. 13 at 7:23 PM
$MLTX Who’s waiting for $25+ to sell a single share?? Charts building pressure and looks primed for a big move soon! 📈
1 · Reply
Bigbadjohn89
Bigbadjohn89 May. 13 at 6:24 PM
0 · Reply
Latest News on MLTX
MoonLake Immunotherapeutics management to meet with BTIG

2026-03-26T17:25:33.000Z - 6 weeks ago

MoonLake Immunotherapeutics management to meet with BTIG


MoonLake price target raised to $70 from $45 at Clear Street

2026-03-11T10:36:37.000Z - 2 months ago

MoonLake price target raised to $70 from $45 at Clear Street


MoonLake Immunotherapeutics Transcript: Investor Day 2026

Feb 23, 2026, 8:00 AM EST - 2 months ago

MoonLake Immunotherapeutics Transcript: Investor Day 2026


MoonLake announces results from Phase 2 trial of Sonelokimab

2026-02-22T19:15:48.000Z - 2 months ago

MoonLake announces results from Phase 2 trial of Sonelokimab


MoonLake price target raised to $32 from $26 at H.C. Wainwright

2026-01-09T11:15:53.000Z - 4 months ago

MoonLake price target raised to $32 from $26 at H.C. Wainwright


thezat
thezat May. 13 at 8:37 PM
$MLTX another day closer to a pop or a drop!
1 · Reply
Creisi
Creisi May. 13 at 8:23 PM
$MLTX Preplanned share sale adopted under Rule 10b-5 of the SEC Rules back in 2025... details are disclosed on the filing. This makes this transaction meaningless in terms of how insiders view the company's future. This is actually the last few shares from the 10b-5 TRADING PLAN, which saw the April disposition under the same preplanned dispositions. See attached:
2 · Reply
AXMO
AXMO May. 13 at 8:17 PM
$MLTX https://ir.moonlaketx.com/sec-filings/sec-filing/4/0001213900-26-055799
1 · Reply
Cardwizard
Cardwizard May. 13 at 8:10 PM
$MLTX oh boy up 19 pennies we’re breaking all kind of records now ,, oh well I guess Green is Green, but I could’ve made more today in my fucking savings account at my local bank. 🏦
0 · Reply
insomniaot7
insomniaot7 May. 13 at 8:04 PM
$MLTX congrats on the green day! Didn't even have to fly to China LOL
0 · Reply
TradesTyrone
TradesTyrone May. 13 at 7:45 PM
$MLTX wen 60
0 · Reply
kuwoson
kuwoson May. 13 at 7:25 PM
$MLTX At what point will there be new buyout offers (assuming big pharma is seriously considering one)? I'm not familiar with the mechanisms for acquisitions in the pharmaceutical industry, but isn't there a risk for potential buyers that an acquisition will become increasingly expensive?
1 · Reply
Rockybhai7239
Rockybhai7239 May. 13 at 7:25 PM
$MLTX how can you miss blackrock 1M shares 256% increase
0 · Reply
EZ_Money11
EZ_Money11 May. 13 at 7:23 PM
$MLTX Who’s waiting for $25+ to sell a single share?? Charts building pressure and looks primed for a big move soon! 📈
1 · Reply
Bigbadjohn89
Bigbadjohn89 May. 13 at 6:24 PM
0 · Reply
LouKojak
LouKojak May. 13 at 5:49 PM
$MLTX JP Morgan big buy
6 · Reply
septrading
septrading May. 13 at 5:46 PM
$BMEA $MLTX are both priced like broken or half-credited stories, but their next datasets will force the market to re-rate them as platform companies overnight. For BMEA, credible early weight-loss from oral GLP-1 candidate BMF-650 would move it out of diabetes optionality and into the hottest obesity trade in biotech, while Icovamenib’s longer-dosing programs keeps the beta-cell regeneration story alive. For MLTX, 52-week VELA durability, adolescent HS confirmation in VELA-TEEN, and a clean IZAR-1 PsA win will turn Sonelokimab from a disputed HS asset into a multi-indication IL-17A/F franchise with BLA visibility, scarcity value, and obvious strategic appeal to immunology buyers. In both cases, the setup is explosive because the market is not paying for clean, compounding data; it is paying for skepticism — and when skepticism has to cover, triples happen fast. Know what you own.
0 · Reply
midas7576
midas7576 May. 13 at 5:19 PM
0 · Reply
Cardwizard
Cardwizard May. 13 at 4:46 PM
$MLTX finally the damn thing looks like it’s starting to climb. It’s about goddamn time. 
0 · Reply
AXMO
AXMO May. 13 at 4:41 PM
0 · Reply
Jkm11
Jkm11 May. 13 at 4:41 PM
0 · Reply
impossiblepub
impossiblepub May. 13 at 4:06 PM
0 · Reply
AXMO
AXMO May. 13 at 4:04 PM
0 · Reply
G_Ho
G_Ho May. 13 at 4:00 PM
0 · Reply
Obidagreat
Obidagreat May. 13 at 3:47 PM
0 · Reply
Bigbadjohn89
Bigbadjohn89 May. 13 at 3:33 PM
0 · Reply
sh3r1ock
sh3r1ock May. 13 at 3:24 PM
$MLTX me holding onto shares as the missed opportunity cost here keeps building
2 · Reply